<html>
<head>PUBMED IDs for UGT2B9</head>
<body bgcolor='#C5F0F2'><h1>UGT2B9</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7835904/'>Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13.</a> September 15  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/9364930/'>Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey.</a> November 19  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/10579317/'>UGT2B23, a novel uridine diphosphate-glucuronosyltransferase enzyme expressed in steroid target tissues that conjugates androgen and estrogen metabolites.</a> December 1  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/12694866/'>Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily.</a> April 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12694817/'>Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma.</a> April 16  2003<br></body></html>
